Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome. (2022)
Attributed to:
Targeting ERK and mTOR for the treatment of fragile X syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-30979-0
PubMed Identifier: 35688821
Publication URI: http://europepmc.org/abstract/MED/35688821
Type: Journal Article/Review
Volume: 13
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723